Archive for December, 2008

Clinical Psychiatry News - Abuse of bupropion

Tuesday, December 30th, 2008

The Problem
You work in one of America’s contemporary long-term psychiatric treatment centers, also known as a state prison. Inmates who come to outpatient appointments and complain of depressive symptoms frequently request bupropion (Wellbutrin). The history they provide is speciously similar: “It’s the only antidepressant that’s ever worked.” You start to inquire about how this medication is …

Clinical Psychiatry News - Bupropion no help longer term

Sunday, December 28th, 2008

The antidepressant bupropion hydrochloride does not significantly increase longer-term smoking cessation rates for some patients, despite several recent studies touting its use for this purpose, Dr. Joel A. Simon and his colleagues reported.
In a randomized, blinded trial conducted in the San Francisco Veterans Affairs Medical Center of 244 veterans who were moderate to heavy smokers, 121 subjects received a 7-week course of bupropion and 123 received placebo. All subjects were given 2…

Clinical Psychiatry News - Bupropion boosts smoking cessation in blacks

Wednesday, December 24th, 2008

The use of sustained-release bupropion can improve smoking-cessation rates in African Americans in conjunction with culturally sensitive counseling, said Dr. Jasjit S. Ahluwalia of the University of Kansas, Kansas City, and colleagues.
In what they called the larg…

Clinical Psychiatry News - Bupropion may aid weight loss

Saturday, December 20th, 2008

WASHINGTON — Bupropion SR is an effective antidepressant that also may aid weight loss, investigators said at the annual scientific assembly of the Southern Medical Association.
Obese patients taking bupropion SR (Wellbutrin) lost significantly more weight than obese patient…

Business Wire - Biovail Launches Wellbutrin XL to Canadian Physicians

Tuesday, December 16th, 2008

TORONTO — Biovail Corporation (NYSE:BVF)(TSX:BVF) announced today that Wellbutrin(R) XL, the first once-daily extended-release formulation of bupropion hydrochloride approved for the Canadian market for the treatment of depression in adults, has been officially launched and is commercially available.
Wellbutrin(R) XL, is being marketed and distributed by Biovail Pharmaceuticals …

A Non-Nicotine Pill that Helps You Stop Smoking

Saturday, December 13th, 2008

Even as you are reading this, advances are being made in the field of medications designed to help you quit smoking. As it happens, a new application as a stop smoking aid has been found for a medication that has been around for some time. While it won’t eliminate all of your cravings by itself, it can help. There is no panacea f…

Canadian Corporate News - Biovail Aware of Second Paragraph IV Certification for Wellbutrin XL.

Thursday, December 11th, 2008

TORONTO, Nov 19, 2004 (CCNMatthews via COMTEX)
Biovail Corporation (NYSE:BVF) (TSX:BVF) has been advised that GlaxoSmithKline (GSK) has received a Notice of Patent Certification associated with an abbreviated new drug application (ANDA) that has been submi…

Nutrition Health Review - When used with nicotine replacement therapy and cognitive-behavioral counseling, bupropion did not improve one-year smoking cessation rates

Monday, December 8th, 2008

Business Editors/Health/Medical Writers
LAURELTON, N.Y.–(BUSINESS WIRE)–Dec. 29, 2003
Eon Labs (Nasdaq: ELAB) announced today that the U.S. District Court for the Southern District of New York repl…

Business Wire - Orexigen® Therapeutics Announces That Contrave® May Reverse the Incidence of Metabolic Syndrome

Thursday, December 4th, 2008

Shows Potential to Reduce Risks for Diabetes and Heart Disease
SAN FRANCISCO & SAN DIEGO — Orexigen([R]) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of central nervous system disorders, including obesity, today announced that based on a review of data from its Contrave([R]) Phase IIb trial, patients assigned to Contrave dosage groups demonstrated a 50% reduction in the prevalence…

Canadian Corporate News - Biovail Comments on Wellbutrin XL Global Marketing Status.

Monday, December 1st, 2008

TORONTO, ONTARIO, Dec 9, 2003 (CCNMatthews via COMTEX)

Most Popular
10 Jobs That Pay $30 An Hour
3 Questions No Job Seeker Ever Wants To Be Asked?
5 Regular Mistakes In Public Speak…